mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
University Hospital Schleswig-Holstein
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Johns Hopkins University
UNICANCER
Swiss Cancer Institute
Alliance for Clinical Trials in Oncology
Federation Francophone de Cancerologie Digestive
Alliance for Clinical Trials in Oncology
The First Affiliated Hospital of Henan University of Science and Technology
University of Oxford